Abstract:
The present invention provides a process for nitrating aromatic compounds without the need for a solid catalyst and/or any organic solvents and/or any other additives. A typical process includes combining or admixing a nitric acid and an anhydride compound under conditions sufficient to produce a reactive intermediate. The aromatic compound to be nitrated is then added to this reactive intermediate to produce a nitroaromatic compound. The nitroaromatic compound can be substituted with one or more, typically, one to three, and often one or two nitrate (-NO 2 ) groups.
Abstract:
The present invention provides a carbon fiber that is coated with a composite material. The composite material coating comprises a sulfonated tetrafluoroethylene based ionomer. The present invention also provides a method for producing and using the same. Some aspects of the invention provide a carbon fiber comprising a substantially uniformly coated composite material. In some embodiments, the term "substantially uniformly coated" refers to having a variation of thickness of the coating of about 25% or less, typically about 20% or less, often about 15% or less, more often about 10% or less, and most often about 5% or less throughout at least about 90%, typically at least about 95% and most often at least 98% of the length of the coated carbon fiber.
Abstract:
The present invention provides a method for treating a clinical condition associated with underexpression of BCL2 gene. In particular, the present invention provides a method for treating a clinical condition associated with underexpression of BCL2 gene by administering a compound that increases i-motif structure of BCL2 gene thereby increasing the expression of BCL2 gene.
Abstract:
The present invention provides isolated polypeptides having nitrile hydratase activity and isolated polynucleotides encoding said polypeptides. The invention also provides nucleic acid constructs, vectors, and host cells comprising said polynucleotides as well as methods of producing and using said polypeptides.
Abstract:
The present invention provides oligopeptides, in particular, Ang-(1-7) derivatives, and methods for using and producing the same. In one particular embodiment, oligopeptides of the invention have higher blood-brain barrier penetration and/or in vivo half-life compared to the native Ang-(1-7), thereby allowing oligopeptides of the invention to be used in a wide variety of clinical applications including in treatment of cognitive dysfunction and/of impairment.
Abstract:
The present invention provides a system and a method for detecting or determining a possible fraudulent information provided by a subject using the subject's behavioral biometric during an application filing process using an electronic input device.
Abstract:
The present invention provides compositions and methods for treating cognitive impairment or dysfunction in a subject. In particular, the present invention provides a method for using a composition comprising an angiotensin-(l-7) receptor agonist to treat cognitive dysfunction or impairment that is due to a various clinical conditions including, but not limited to, those associated with increase in inflammation, cytokine production, increases in reactive oxygen species, changes in expression of brain inflammatory related genes and/or in the expression of genes involved in learning and memory within the central nervous system of a subject.
Abstract:
The present invention provides a system and a method for detecting a neuromotor disorder or condition in a subject using an electronic device that comprises an input device. The method generally involves determining input device usage characteristics of the subject and comparing the result to a reference input device usage characteristic.
Abstract:
The present invention provides a system and a method for detecting a neuromotor disorder or condition in a subject using an electronic device that comprises an input device. The method generally involves determining input device usage characteristics of the subject and comparing the result to a reference input device usage characteristic.
Abstract:
The present invention provides a system and a method for eliciting information to sensitive questions and reliably detecting whether one is being deceptive, concealing information, or experiencing a heightened emotional response to the question. In particular, the system and the method of the invention are based on analyzing the user behavioral biometric of using one or more input device(s).